Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients

被引:28
|
作者
Garcia-Azorin, David [1 ,2 ]
Trigo, Javier [1 ]
Talavera, Blanca [1 ]
Martinez-Pias, Enrique [1 ]
Sierra, Alvaro [1 ]
Porta-Etessam, Jesus [3 ,4 ]
Arenillas, Juan F. [1 ,5 ,6 ]
Guerrero, Angel L. [1 ,2 ,6 ]
机构
[1] Hosp Clin Univ Valladolid, Dept Neurol, Headache Unit, Ave Ramon y Cajal 3, Valladolid 47005, Spain
[2] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain
[3] Hosp Clin San Carlos, IdISSC, Inst Neurosci, Headache Unit,Dept Neurol, Madrid, Spain
[4] Univ Complutense Madrid, Dept Med, Madrid, Spain
[5] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Neurovasc Res Lab, Madrid, Spain
[6] Univ Valladolid, Sch Med, Dept Med, Valladolid, Spain
来源
HEADACHE | 2020年 / 60卷 / 08期
关键词
Covid-19; neurology; headache; coronavirus; diagnosis; EMERGENCY-DEPARTMENT; MANAGEMENT; MIGRAINE; DISEASE;
D O I
10.1111/head.13927
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19. Background Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags. Design and Methods Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission. Results We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation: 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases. Conclusion In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.
引用
收藏
页码:1664 / 1672
页数:9
相关论文
共 50 条
  • [21] Use of convalescent plasma in hospitalized patients with COVID-19: case series
    Hegerova, Livia
    Gooley, Ted A.
    Sweerus, Kelly A.
    Maree, Cynthia
    Bailey, Neil
    Bailey, Megumi
    Dunleavy, Vanessa
    Patel, Krish
    Alcorn, Kirsten
    Haley, Rebecca
    Johnsen, Jill M.
    Konkle, Barbara A.
    Lahti, Annamarie C.
    Alexander, Morgan L.
    Goldman, Jason D.
    Lipke, Anne
    Lim, Sun-jung
    Sullivan, Mark D.
    Pauk, John S.
    Pagel, John M.
    BLOOD, 2020, 136 (06) : 759 - 762
  • [22] Remdesivir in hospitalized COVID-19 Patients
    Thiem, Helena
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (03): : 111 - +
  • [23] Eight hospitalized patients with COVID-19
    Agrawal, Purvesh
    Khandelwal, Nidhi
    JOURNAL OF MARINE MEDICAL SOCIETY, 2020, 22 (03) : 124 - 127
  • [24] Dexamethasone in Hospitalized Patients with Covid-19
    Horby, Peter
    Lim, Wei Shen
    Emberson, Jonathan R.
    Mafham, Marion
    Bell, Jennifer L.
    Linsell, Louise
    Staplin, Natalie
    Brightling, Christopher
    Ustianowski, Andrew
    Elmahi, Einas
    Prudon, Benjamin
    Green, Christopher
    Felton, Timothy
    Chadwick, David
    Rege, Kanchan
    Fegan, Christopher
    Chappell, Lucy C.
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Montgomery, Alan
    Rowan, Kathryn
    Juszczak, Edmund
    Baillie, J. Kenneth
    Haynes, Richard
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08): : 693 - 704
  • [25] Managing hospitalized patients with COVID-19
    Stricker, Mike
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (10): : 16 - 21
  • [26] Hyperlipasemia in Hospitalized COVID-19 Patients
    Kenner, Maria
    Sferra, Joseph
    Sutton, Jeffrey M.
    Redfern, Roberta
    Syed, Kristin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : E110 - E111
  • [27] Epistaxis in hospitalized patients with COVID-19
    Dell'Era, Valeria
    Dosdegani, Riccardo
    Valletti, Paolo Aluffi
    Garzaro, Massimiliano
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
  • [28] Tocilizumab for hospitalized patients with COVID-19
    Afra, Kevin
    Chen, Luke Y. C.
    Sweet, David
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (15) : E521 - E521
  • [29] Anticoagulation in Hospitalized Patients with Covid-19
    Chowdhury, Jehan F.
    Moores, Lisa K.
    Connors, Jean M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1675 - 1678
  • [30] AKI in Hospitalized Patients with COVID-19
    Chan, Lili
    Chaudhary, Kumardeep
    Saha, Aparna
    Chauhan, Kinsuk
    Vaid, Akhil
    Zhao, Shan
    Paranjpe, Ishan
    Somani, Sulaiman
    Richter, Felix
    Miotto, Riccardo
    Lala, Anuradha
    Kia, Arash
    Timsina, Prem
    Li, Li
    Freeman, Robert
    Chen, Rong
    Narula, Jagat
    Just, Allan C.
    Horowitz, Carol
    Fayad, Zahi
    Cordon-Cardo, Carlos
    Schadt, Eric
    Levin, Matthew A.
    Reich, David L.
    Fuster, Valentin
    Murphy, Barbara
    He, John C.
    Charney, Alexander W.
    Boettinger, Erwin P.
    Glicksberg, Benjamin S.
    Coca, Steven G.
    Nadkarni, Girish N.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 151 - 160